Trading Update

London, 10 January 2013 Sinclair IS Pharma plc (AIM:SPH.L) ("Sinclair IS" or the "Group"), the international specialty pharma company, announces a trading update for the six months ended 31
December 2012 ahead of its interim results which will be announced on 12 February 2013.
• Revenues for the first half expected to be approximately £23.0 million, +4% like-for like
("LFL")
• Continued strong growth of International operations, +18% LFL
• Sculptra/New-Fill and Succeev sales recently commenced
• New debt facility recently secured to provide additional capital of £9.0 million for future business development opportunities

Trading update

Revenues for the six months ended 31 December 2012 were approximately £23.0 million, compared to £23.4 million for the same period last year, which is in